Back
Enbridge, Inc. 10K Form
Buy
81
ENB
Enbridge, Inc.
Last Price:
$52.37
Seasonality Move:
5.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | ENB/Enbridge, Inc. Quarterly |
| 2023-11-03 | 10Q | ENB/Enbridge, Inc. Quarterly |
| 2023-08-04 | 10Q | ENB/Enbridge, Inc. Quarterly |
| 2023-05-05 | 10Q | ENB/Enbridge, Inc. Quarterly |
| 2022-11-04 | 10Q | ENB/Enbridge, Inc. Quarterly |
| 2022-07-29 | 10Q | ENB/Enbridge, Inc. Quarterly |
Receive ENB News And Ratings
See the #1 stock for the next 7 days that we like better than ENB
ENB Financial Statistics
Sales & Book Value
| Annual Sales: | $46.6B |
|---|---|
| Cash Flow: | $151.2M |
| Price / Cash Flow: | 41.51 |
| Annual Sales: | $18.56 |
| Price / Book: | 2.78 |
Profitability
| EPS (TTM): | 2.30510 |
|---|---|
| Net Income (TTM): | $5.6B |
| Gross Margin: | $15.2B |
| Return on Equity: | 11.33% |
| Return on Assets: | 3.58% |
Enbridge, Inc. Earnings Forecast
Key Enbridge, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for ENB is 32.61%.
-
The Selling, General & Administrative Expenses for ENB have been equal to 15.31% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 64.66% of Operating Income.
-
The Net Earning history of ENB is 11.96% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 14 years.
Enbridge, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | ENB |
| CUSIP: | 29250N |
| Website: | enbridge.com |
Debt
| Debt-to-Equity Ratio: | 1.7 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0.4 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.25 |
|---|---|
| Forward P/E Ratio: | 21.96 |
ENB Technical Analysis vs Fundamental Analysis
Buy
81
Enbridge, Inc. (ENB)
is a Buy
Is Enbridge, Inc. a Buy or a Sell?
-
Enbridge, Inc. stock is rated a BuyThe current Enbridge, Inc. [ENB] share price is $51.52. The Score for ENB is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.